BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chou JY, Jun HS, Mansfield BC. Neutropenia in type Ib glycogen storage disease. Curr Opin Hematol. 2010;17:36-42. [PMID: 19741523 DOI: 10.1097/moh.0b013e328331df85] [Cited by in Crossref: 54] [Cited by in F6Publishing: 22] [Article Influence: 4.9] [Reference Citation Analysis]
Number Citing Articles
1 Wan J, Zhang ZC, Yang MQ, Sun XM, Yin L, Chen CQ. Minimally invasive surgery for glycogen storage disease combined with inflammatory bowel disease: A case report. World J Clin Cases 2021;9:4342-7. [PMID: 34141799 DOI: 10.12998/wjcc.v9.i17.4342] [Reference Citation Analysis]
2 Kim GY, Lee YM, Kwon JH, Jun HS, Chou J. Glycogen storage disease type Ib neutrophils exhibit impaired cell adhesion and migration. Biochem Biophys Res Commun 2017;482:569-74. [PMID: 27864142 DOI: 10.1016/j.bbrc.2016.11.075] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]
3 Chou JY, Sik Jun H, Mansfield BC. The SLC37 family of phosphate-linked sugar phosphate antiporters. Mol Aspects Med 2013;34:601-11. [PMID: 23506893 DOI: 10.1016/j.mam.2012.05.010] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
4 Nordlie RC, Foster JD. A retrospective review of the roles of multifunctional glucose-6-phosphatase in blood glucose homeostasis: Genesis of the tuning/retuning hypothesis. Life Sci 2010;87:339-49. [PMID: 20603134 DOI: 10.1016/j.lfs.2010.06.021] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
5 Melis D, Minopoli G, Balivo F, Marcolongo P, Parini R, Paci S, Dionisi-Vici C, Della Casa R, Benedetti A, Andria G, Parenti G. Vitamin E Improves Clinical Outcome of Patients Affected by Glycogen Storage Disease Type Ib. JIMD Rep 2016;25:39-45. [PMID: 26122627 DOI: 10.1007/8904_2015_461] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
6 Froissart R, Piraud M, Boudjemline AM, Vianey-Saban C, Petit F, Hubert-Buron A, Eberschweiler PT, Gajdos V, Labrune P. Glucose-6-phosphatase deficiency. Orphanet J Rare Dis. 2011;6:27. [PMID: 21599942 DOI: 10.1186/1750-1172-6-27] [Cited by in Crossref: 100] [Cited by in F6Publishing: 67] [Article Influence: 10.0] [Reference Citation Analysis]
7 Jun HS, Cheung YY, Lee YM, Mansfield BC, Chou JY. Glucose-6-phosphatase-β, implicated in a congenital neutropenia syndrome, is essential for macrophage energy homeostasis and functionality. Blood 2012;119:4047-55. [PMID: 22246029 DOI: 10.1182/blood-2011-09-377820] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 3.9] [Reference Citation Analysis]
8 Chou JY, Mansfield BC. The SLC37 family of sugar-phosphate/phosphate exchangers. Curr Top Membr 2014;73:357-82. [PMID: 24745989 DOI: 10.1016/B978-0-12-800223-0.00010-4] [Cited by in Crossref: 32] [Cited by in F6Publishing: 16] [Article Influence: 4.6] [Reference Citation Analysis]
9 Cappello AR, Curcio R, Lappano R, Maggiolini M, Dolce V. The Physiopathological Role of the Exchangers Belonging to the SLC37 Family. Front Chem 2018;6:122. [PMID: 29719821 DOI: 10.3389/fchem.2018.00122] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
10 Xu Q, Tang H, Duan L, Zuo X, Shi X, Li Y, Zhao H, Zhang H. A novel SLC37A4 missense mutation in GSD-Ib without hepatomegaly causes enhanced leukocytes endoplasmic reticulum stress and apoptosis. Mol Genet Genomic Med 2021;9:e1568. [PMID: 33280276 DOI: 10.1002/mgg3.1568] [Reference Citation Analysis]
11 Visser G, de Jager W, Verhagen LP, Smit GP, Wijburg FA, Prakken BJ, Coffer PJ, Buitenhuis M. Survival, but not maturation, is affected in neutrophil progenitors from GSD-1b patients. J Inherit Metab Dis 2012;35:287-300. [PMID: 21863279 DOI: 10.1007/s10545-011-9379-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
12 Lyons JJ, Milner JD, Rosenzweig SD. Glycans Instructing Immunity: The Emerging Role of Altered Glycosylation in Clinical Immunology. Front Pediatr 2015;3:54. [PMID: 26125015 DOI: 10.3389/fped.2015.00054] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 6.7] [Reference Citation Analysis]
13 Grünert SC, Elling R, Maag B, Wortmann SB, Derks TGJ, Hannibal L, Schumann A, Rosenbaum-Fabian S, Spiekerkoetter U. Improved inflammatory bowel disease, wound healing and normal oxidative burst under treatment with empagliflozin in glycogen storage disease type Ib. Orphanet J Rare Dis 2020;15:218. [PMID: 32838757 DOI: 10.1186/s13023-020-01503-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
14 Qian F, Guo X, Wang X, Yuan X, Chen S, Malawista SE, Bockenstedt LK, Allore HG, Montgomery RR. Reduced bioenergetics and toll-like receptor 1 function in human polymorphonuclear leukocytes in aging. Aging (Albany NY) 2014;6:131-9. [PMID: 24595889 DOI: 10.18632/aging.100642] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 4.3] [Reference Citation Analysis]
15 Davies LC, Rice CM, McVicar DW, Weiss JM. Diversity and environmental adaptation of phagocytic cell metabolism. J Leukoc Biol 2019;105:37-48. [PMID: 30247792 DOI: 10.1002/JLB.4RI0518-195R] [Cited by in Crossref: 23] [Cited by in F6Publishing: 10] [Article Influence: 7.7] [Reference Citation Analysis]
16 Chou JY, Jun HS, Mansfield BC. Glycogen storage disease type I and G6Pase-β deficiency: etiology and therapy. Nat Rev Endocrinol 2010;6:676-88. [PMID: 20975743 DOI: 10.1038/nrendo.2010.189] [Cited by in Crossref: 126] [Cited by in F6Publishing: 103] [Article Influence: 11.5] [Reference Citation Analysis]
17 Chou JY, Cho JH, Kim GY, Mansfield BC. Molecular biology and gene therapy for glycogen storage disease type Ib. J Inherit Metab Dis 2018;41:1007-14. [PMID: 29663270 DOI: 10.1007/s10545-018-0180-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
18 Melis D, Carbone F, Minopoli G, La Rocca C, Perna F, De Rosa V, Galgani M, Andria G, Parenti G, Matarese G. Cutting Edge: Increased Autoimmunity Risk in Glycogen Storage Disease Type 1b Is Associated with a Reduced Engagement of Glycolysis in T Cells and an Impaired Regulatory T Cell Function. J Immunol 2017;198:3803-8. [PMID: 28389590 DOI: 10.4049/jimmunol.1601946] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 7.3] [Reference Citation Analysis]
19 Furutani E, Newburger PE, Shimamura A. Neutropenia in the age of genetic testing: Advances and challenges. Am J Hematol 2019;94:384-93. [PMID: 30536760 DOI: 10.1002/ajh.25374] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
20 Wicker C, Roda C, Perry A, Arnoux JB, Brassier A, Castelle M, Servais A, Donadieu J, Bouchereau J, Pigneur B, Labrune P, Ruemmele FM, de Lonlay P. Infectious and digestive complications in glycogen storage disease type Ib: Study of a French cohort. Mol Genet Metab Rep. 2020;23:100581. [PMID: 32300528 DOI: 10.1016/j.ymgmr.2020.100581] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
21 Jun HS, Weinstein DA, Lee YM, Mansfield BC, Chou JY. Molecular mechanisms of neutrophil dysfunction in glycogen storage disease type Ib. Blood. 2014;123:2843-2853. [PMID: 24565827 DOI: 10.1182/blood-2013-05-502435] [Cited by in Crossref: 64] [Cited by in F6Publishing: 55] [Article Influence: 9.1] [Reference Citation Analysis]
22 Boers SJ, Visser G, Smit PG, Fuchs SA. Liver transplantation in glycogen storage disease type I. Orphanet J Rare Dis. 2014;9:47. [PMID: 24716823 DOI: 10.1186/1750-1172-9-47] [Cited by in Crossref: 31] [Cited by in F6Publishing: 17] [Article Influence: 4.4] [Reference Citation Analysis]